Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

Research output: Contribution to journalComment/debateResearchpeer-review

  1. The incomplete story of complete mesocolic excision - Authors' reply

    Research output: Contribution to journalLetterResearch

  2. 5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Access to radiotherapy among circumpolar Inuit populations

    Research output: Contribution to journalReviewResearchpeer-review

  1. Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalLancet Oncology
Volume21
Issue number2
Pages (from-to)193-194
Number of pages2
ISSN1470-2045
DOIs
Publication statusPublished - Feb 2020

ID: 59523149